LeafNLP Demos
Back to explore

Report #2871620

Received Nov 10, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Nov 6, 2025
Onset
Nov 6, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKLN4P2—

Symptoms (1)

Expired product administered

Symptom narrative

Arexvy expired dose administered; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a patient who received RSVPreF3 adjuvanted (Arexvy) (batch number LN4P2, expiry date 01-NOV-2025) for prophylaxis. On 06-NOV-2025, the patient received Arexvy. On 06-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Arexvy Expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 06-NOV-2025 A doctor reported the administration of an expired dose of Arexvy to two different patients. The vaccine was expired on 01-NOV-2025. It was administered today on 06-NOV-2025. The doctor wanted to know if the patients needed to be revaccinated and if there were any side effects. This case is linked to case US2025144502 from the same reporter.; Sender's Comments: US-GSK-US2025144502:2nd patient case